Donald Wuchterl
Director/Board Member presso ABEONA THERAPEUTICS INC.
Patrimonio netto: 545 033 $ in data 31/03/2024
Profilo
Donald A.
Wuchterl is an Independent Director at Abeona Therapeutics, Inc. and Senior VP & Chief Manufacturing Officer at T-Knife Therapeutics, Inc. He was previously the Chief Operating Officer & Senior Vice President at Cytovance Biologics, Inc. and Senior VP-Technical Operations & Quality at Astellas Gene Therapies, Inc. He holds an undergraduate degree from Colorado Technical University, Inc. and an MBA from Fitchburg State University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 01/03/2024 | 75 177 ( 0.27% ) | 545 033 $ | 31/03/2024 |
Posizioni attive di Donald Wuchterl
| Società | Posizione | Inizio |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Director/Board Member | 19/04/2021 |
| T-Knife Therapeutics, Inc. | Corporate Officer/Principal | - |
Precedenti posizioni note di Donald Wuchterl
| Società | Posizione | Fine |
|---|---|---|
| AUDENTES THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2021 |
Cytovance Biologics, Inc.
 Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Chief Operating Officer | - |
Formazione di Donald Wuchterl
| Colorado Technical University, Inc. | Undergraduate Degree |
| Fitchburg State University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ABEONA THERAPEUTICS INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Cytovance Biologics, Inc.
Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Health Technology |
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA. | Health Technology |
| T-Knife Therapeutics, Inc. |
- Borsa valori
- Insiders
- Donald Wuchterl
